Juniper Pharmaceuticals focuses on developing therapeutics that address unmet medical needs in women's health. The company develops its products using its drug delivery technologies and a novel intra-vaginal ring (IVR) technology. It markets Crinone, which is commercially available in the United States and over 90 countries around the world. Its current intravaginal ring (IVR) product candidates are JNP-0101, JNP-0201 and JNP-0301. Juniper Pharmaceuticals, Inc. was founded in 1986 and is headquartered in Boston, Massachusetts.